Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to -$0.0.

  • Pharma-Bio Serv's EPS (Basic) fell 10063.36% to -$0.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$0.0, marking a year-over-year decrease of 10063.36%. This contributed to the annual value of -$0.0 for FY2025, which is 8707.01% up from last year.
  • Latest data reveals that Pharma-Bio Serv reported EPS (Basic) of -$0.0 as of Q4 2025, which was down 10063.36% from -$0.01 recorded in Q3 2025.
  • Pharma-Bio Serv's EPS (Basic)'s 5-year high stood at $0.1 during Q3 2021, with a 5-year trough of -$0.21 in Q4 2021.
  • In the last 5 years, Pharma-Bio Serv's EPS (Basic) had a median value of $0.01 in 2022 and averaged -$0.0.
  • Examining YoY changes over the last 5 years, Pharma-Bio Serv's EPS (Basic) showed a top increase of 22930.9% in 2021 and a maximum decrease of 362688.7% in 2021.
  • Over the past 5 years, Pharma-Bio Serv's EPS (Basic) (Quarter) stood at -$0.21 in 2021, then soared by 103.56% to $0.01 in 2022, then crashed by 127.23% to -$0.0 in 2023, then surged by 134.18% to $0.0 in 2024, then tumbled by 100.63% to -$0.0 in 2025.
  • Its EPS (Basic) was -$0.0 in Q4 2025, compared to -$0.01 in Q3 2025 and $0.0 in Q2 2025.